Hester Biosciences exploring various opportunities to increase product portfolio

29 Oct 2018 Evaluate

Hester Biosciences is exploring various opportunities to increase the product portfolio and turnover. The company has reported net sales of Rs 80.80 crore in H1FY19 as compared to Rs 67.52 crore for the corresponding period of previous year, registering a growth of around 20%.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Hester Biosciences Share Price

1459.75 -44.65 (-2.97%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1673.55
Dr. Reddys Lab 1166.45
Cipla 1391.20
Zydus Lifesciences 881.10
Lupin 2178.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×